• locale

  United States

• market

  PRIVATE

• industry

  Medical Diagnostics

• website

  www.universaldx.com

Universal Diagnostics applies multi-omics, computational biology and machine learning approaches to develop blood tests for detecting gastrointestinal cancers. Their first blood test, Signal-C®, detects colorectal cancer with a sensitivity of 92% and a specificity of 94%.